维普期刊资源整合服务平台（V6.5）

284篇 您的检索式：作者名="POYNARD T"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	An algorithm for the grading of activity in chronic hepatitis C显示文摘	P Bedossa T Poynard	1996	Hepatology1996，，2：	8
2	Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome显示文摘	Regimbeau C Benhamou Y	2001	Aliment Pharmacol Ther2001，15，3：	1
3	Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multi- center study 显示文摘	Moreau R Durand F Poynard T	2002	Gatroenterology2002，122，4：	1
4	Meta-analys is of interferon randomized trials in the treatment of viral hepatitis C B effects of do and duration显示文摘	Poynard T Leroy V Cohard M	1996	Hepatology1996，24，：	1
5	Fac- tors associated with serum alanine transaminase ac- tivity in healthy subjects: consequences for the defini tion of normal values, { or selection of blood donors, and for patients with chronic hepatitis C显示文摘	Piton A Poynard T Imbert Bismut F etal	1998	Hepatol- ogy1998，27，5：	1
6	Meta - analyses of FibroTest diagnostic value in chronic liver disease 显示文摘	Poynard T Morra R Halfon P	2007	BMC Gastroenterol2007，7，：	1
7	Association between lep tin,metabolic factors and liver histology in patients with chronic hepatitis C显示文摘	Myers RP Messous D Poynard T	2007	Can J Gastroenterol2007，21，5：	1
8	Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fi- brosis stages显示文摘	Poynard T Halfon P Castera L	2007	Clin Chem2007，53，9：	1
9	Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers:influence of 'a' determinant variants显示文摘	Lada O Benhamou Y Poynard T		0，，：	1
10	Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of 'a' determinant variants显示文摘	Lada O Benhamou Y Poynard T	2006	J Virol2006，80，6：	1
11	Coexistence of hepatitis B surface antigen(HBsAg) and anti-HBs antibodies in chronic hepa- titis B virus carriers: influence of 'α' determinant variants 显示文摘	LADA O BENHAMOU Y POYNARD T	2006	J Viro12006，80，6：	1
12	Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interfe- ron alfa/ribavirin therapy 显示文摘	Poynard T Colombo M Bruix J	2009	Gastroenterology2009，136，5：	1
13	Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus显示文摘	Poynard T Mareellln P Lee SS Minuk GS Ideo G Bain V Heathcote J Zeuzem S Trepo C Albrecht J		0，，：	1
14	Slow regression of livel fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C显示文摘	Poynard T Moussalli J Munteanu M	2013	J Hepatol2013，59，4：	1
15	A comparison of fibrosis progression in chronic liver diseases显示文摘	Poynard T Mathurin P Lai CL	2003	J Hepatol2003，38，3：	1
16	Fibrosis as an end point for clinical trials in liver disease : a report of the international fibresis group 显示文摘	McHutchison J Poynard T Afdhal N	2006	Clin Gastroenterol Hepatol2006，4，10：	1
17	Diagnostic value of Fibro test with normal serum aminotransforases显示文摘	Poynard T Munteanu M Ngo Y	2006	Hepatology2006，43，2：	1
18	Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin显示文摘	Poynard T McHutchison J Manns M	2003	Hepatology2003，38，2：	1
19	Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin显示文摘	McHutchison J Mannas M	2003	Hepatology2003，38，：	1
20	Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C显示文摘	Poynard T Munteanu M Imbert-Bismut F	2004	Clinical Chemistry2004，50，8：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示